What doesn't exist is Phase III obesity trial data, long-term weight maintenance outcomes, or head-to-head comparisons with approved therapies
The quantity of chylomicron particles does not alter after engaging in either short-term or long-term aerobic activities (77, 78)
Full disclosure
These combination formulations inject identically to standalone versions
Consumers should be skeptical of any over-the-counter product marketed as a GLP-1 supplement that suggests it can act like a prescription drug, replace a GLP-1 medication or treat a disease such as obesity, says Jeff Ventura, a spokesperson for the Council for Responsible Nutrition, which represents the dietary supplement industry
We help clients understand modern wellness optionslike peptide therapy, metabolic health, longevity support, and skincareso they can make informed decisions about their health